Jesper Söderqvist, Ph.D

Board of Directors since 2013

Member of the Remuneration Committee since 2020

Education/Background:  M.Sc.Eng. from KTH Royal Institute of Technology. Ph.D. in Physics from KTH Royal Institute of Technology and CERN. He has previously held the positions of CEO and Board member at Arcoma, Vice President for Elekta AB’s neuroscience division, General Manager for mammography at Philips Healthcare, and CEO at Sectra Mamea.

Current Assignments:  Jesper is CEO of Boule Diagnostics AB, as well as Board member and CEO of Dekatria AB.

Holdings:  directly and indirectly 41,085 Class A shares and 122 236 Class B shares, 27 780 TO3B


Numbers of patients in studies




Pharma Projects

Are you a US resident?

Only US residents will be able to qualify for this program